Metabolic-associated fatty liver disease and major adverse cardiac events in patients with chronic coronary syndrome: a matched case–control study
2021 ◽
Vol 116
(1)
◽
pp. S1326-S1326
Keyword(s):
Keyword(s):
Keyword(s):